trial · primary record
N-acetyl cysteine
Bipolar Disorder
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 70 |
| Primary completion | 2031-08-31 |
| Primary endpoint | Change in dACC glutamate/glutathione levels through Proton Magnetic Resonance |
| Registry ID | NCT07913542 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:48.756Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07913542
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.